About
Radiopharmaceuticals
Areas of Focus
Categories
RadiopharmaceuticalsChina
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
4
As Collaborator
0
Total Enrollment
76
By Phase
EARLY_PHASE1: 3PHASE1: 1
By Status
COMPLETED: 2NOT_YET_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06646783Lead Sponsor
Phase IIT Trial of SNA014
EARLY_PHASE1Not yet recruiting
28 participants
Started: Oct 20, 2024 · Completed: Nov 20, 2025
NCT05989997Lead Sponsor
Phase I Clinical Trial of 68Ga-NOTA-SNA002
PHASE1Completed
17 participants
Started: Nov 1, 2023 · Completed: Nov 8, 2024
NCT05490264Lead Sponsor
[68Ga]Ga-NOTA-SNA002 (PD-L1 PET Tracer) for PET/CT in Patients With Solid Tumors
EARLY_PHASE1Recruiting
20 participants
Started: Oct 18, 2022 · Completed: Jul 30, 2024
NCT05126927Lead Sponsor
A PET Imaging Agent to Assess the Level of Tumor Tissue-infiltrating CD8 + T Cells in Patients With Solid Tumors
EARLY_PHASE1Completed
11 participants
Started: Nov 2, 2021 · Completed: Aug 1, 2022
Locations (1)
Headquarters
Shanghai, China
Map
Loading map...